Zydus receives FDA nod for Morphine Sulfate Tablets

The company has received market authorization for Morphine Sulfate ER Tablets from the US health regulator


Morphine Sulfate Tablets is used in the treatment of pain

Zydus Group has received the final approval from the United States Food and Drug administration (USFDA) to market its Morphine Sulfate ER Tablets, used in the treatment of chronic pain or cancer related pain.

The Tablets will be manufactured by Nesher Pharmaceuticals, located at St.Louis, USA, the company said in afiling to the BSE.

Nesher Pharmaceuticals is a subsidary of Zydus Pharmaceuticals.


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email